Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...

Oral bioavailability of drugs is often limited due to poor solubility and/or limited intestinal permeability. To overcome these issues numerous strategies have been developed, among which lipid-based ...

Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids (Natural v/s ...

Lipid-based formulations offer a means of addressing the physicochemical and biological challenges of poorly soluble APIs. Lipid-based formulations (LBFs) may improve oral bioavailability by ...

Pharmaceutical scientists and biologists are teaming up to make the next generation of lipid nanoparticles (LNPs) for drug delivery. Combining structural biology with cutting edge pharmaceutical ...

Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Lipid Nanoparticles Market Analysis & Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global lipid ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today ...

As the CBD industry continues to flourish, a divergence of well-equipped and well-intentioned manufacturers have distinctly emerged from a body of brands less capable of verifying label claims of CBD ...